On August 18, JBS N.V. (NYSE:JBS) proposed buying out every share of Pilgrim’s Pride Corporation it doesn’t already own, offering 2.086 JBS shares for each PPC share. JBS already controls about 82% of Pilgrim’s Pride, so this isn’t a takeover fight; it’s a cleanup. The timing is awkward, though. The offer landed just over a week after JBS reported a net loss for the quarter, and the market’s reaction to both events says something about how investors are reading the moves.
A Bigger, Simpler Company
For Pilgrim’s Pride shareholders, JBS is framing the deal as an upgrade rather than a buyout. Folding PPC into JBS would eliminate the cost of running it as a separate public company, and JBS says the combined structure allows more flexible capital allocation across the group. Shareholders who take JBS stock instead of PPC stock would also trade a thin public float for a much larger one, with a broader base of institutional buyers than PPC’s minority shares currently draw. JBS Chairman Jeremiah O’Callaghan pointed to sixteen years of the two companies working together, arguing that familiarity with PPC’s operations should mean minimal disruption for employees and customers if the deal closes.
The underlying business gives that pitch some support. JBS posted record net sales of $23.9 billion in the second quarter, up 14% from a year earlier, evidence that the multi-protein, multi-country model keeps growing even when individual segments wobble. Brazil operations posted record second-quarter sales too, helped by strong export demand to China and World Cup-related marketing at home. JBS also joined the Russell 1000 and Russell 3000 indices during the quarter, a move it says will expand its shareholder base and lift the stock’s visibility, exactly the kind of liquidity boost it’s now promising PPC holders directly.
The Profit Problem Underneath
The numbers behind that pitch are less flattering. JBS swung to a net loss of $102 million in the quarter, versus $528 million in profit a year earlier, and adjusted EBITDA fell 18% under IFRS to $1.429 billion. Pilgrim’s Pride, the very unit JBS wants to fully absorb, saw its adjusted EBITDA drop 38.5% to $503 million as its margin fell from 17.2% to 10.9%, hit by weaker chicken commodity pricing even as volumes held up. Beef North America stayed unprofitable on an adjusted basis, though the loss narrowed from $233 million to $78 million, and JBS responded by closing plants in Souderton, Pennsylvania, and Memphis, Tennessee, and merging three beef units into one to cut costs.
Leverage is also creeping up at an inconvenient moment. Net debt sat at 3.1 times adjusted EBITDA, above JBS’s own long-term target and well above the 2.27 times it carried a year earlier, while interest coverage fell to 5.00 times from 7.74 times. And because the PPC proposal pays in stock rather than cash, completing it means issuing new JBS shares against a business whose own profitability just took a hit, a cost current shareholders will absorb even though JBS already owns most of Pilgrim’s Pride outright.
The Market Isn’t Convinced
Hedge fund ownership in JBS fell from 34 funds to 29 in the most recent quarter, a pullback that lines up with the profit swing more than with the acquisition news. The stock trades at just 3.87 times forward earnings as of September 21, a multiple that usually reflects either a hidden bargain or genuine doubt about where earnings go next. Short sellers control 16.77% of the float, a level well above routine hedging and closer to organized skepticism. That combination points toward a market that isn’t yet convinced the buyout solves JBS’s near-term profit problems.
Who Really Holds the Cards
The Pilgrim’s Pride proposal and the second-quarter loss are really the same story told from two angles: JBS simplifying its empire while pieces of that empire struggle. Whether shareholders end up better off hinges on whether the promised savings and deeper liquidity show up faster than poultry and beef margins keep sliding, especially with leverage already above target. A stock this cheap and this heavily shorted suggests the market isn’t yet buying that story. The special committee reviewing the offer, and the minority PPC shareholders who get the final vote, now hold more sway over how this plays out than JBS’s own board.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
Hedge Fund Resource Center